The latest Herceptin biosimilar is branded as Kanjinti (trastuzumab-anns) and is approved in all indications of the reference product. These are for the treatment of HER2-overexpressing adjuvant ...
Pre-Market: 8:33:11 a.m. EDT Loading Chart for AMGN ...
After hours: 13 March at 7:20:24 pm GMT-4 Loading Chart for AMGN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback